CEO Joe Payne told investors at the 38th Annual ROTH Conference that the company is refocusing on rare disease programs after gaining approvals for its COVID-19 vaccine in more than 30 countries. Payn ...
An Australian tech entrepreneur has helped create what appears to be a made-to-measure cancer vaccine for his dog, Rosie ...
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...
A newly identified cellular system monitors subtle variations in genetic coding, hinting at a hidden level of control over ...
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Vietnam Investment Review on MSN
Innorna receives FDA clearance for mRNA metabolic disease trial
HONG KONG SAR, China and SHENZHEN, China and CAMBRIDGE, Mass., March 17, 2026 /PRNewswire/ -- Innorna, a clinical‑stage biotech company advancing RNA medicines, today announced that the U.S. Food and ...
Scientists have developed some incredibly advanced ways to actually visualize gene activity in tissues. A sample of tissue ...
Que.com on MSN
AI-guided LNP design for targeted in vivo mRNA delivery
Messenger RNA (mRNA) therapeutics have moved from a promising idea to clinical reality, accelerating vaccine development and ...
Morning Overview on MSN
Engineered lipid nanoparticles reprogram immune metabolism to boost mRNA
Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting ...
An Australian tech entrepreneur has helped create what appears to be a made-to-measure cancer vaccine for his dog, Rosie, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results